Hershey’s Long-Term Sales Look SWEET and 3 Analyst Alerts in Our Sights

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Hershey Co. (NYSE:HSY) upped its long-term sales and EPS targets, leading Citigroup to repeat its Buy rating on the stock.

CSX Corp. (NYSE:CSX) has been taken off the U.S. Key Call List by UBS due to worse than planned utility coal volumes. Shares are still Buy rated with a $29 price target.

Bristol-Myers Squibb Company (NYSE:BMY): Citigroup thinks that the FDA’s complete response letter regarding Bristol-Myers’ Eliquis ought to be wrapped up soon and cause only a few months’ delay in the American launch of the drug. This will not notably alter the firm’s estimates, as Citigroup stands by a $40 target and Buy rating. Leerink moved its U.S. prediction for Eliquis by a year after the FDA letter, but believes that on press release wording and after conversations with the company, the firm is optimistic that Eliquis’ drug profile will in the end not change. Leerink holds to an Outperform rating on shares.

Western Gas Partners Lp (NYSE:WES): RBC Capital, following a meeting with Western Gas’ management, believes that the company is well-positioned for top-tier distribution expansion in the coming several years. RBC thinks the stock is a compelling chance for total return, and it repeats an Outperform rating on the shares.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business